Taiwanese company Health2Sync is tackling the problem of diabetes in Asia, which accounts for 60% of the world's sufferers. The firm has developed a device that monitors blood sugar levels and sends alerts to smartphone apps when it reaches dangerous levels. Japan is the world’s second largest market for spending on diabetes care, behind only the U.S.. which explains why Health2Sync is making this expansion. Health2Sync said within three months, high-risk users experienced a 22% drop in average blood glucose levels. The company, which recently closed a $6m series B round, aims to expand beyond its main market in Japan into southeast Asia.
Taiwanese company Health2Sync is tackling the problem of diabetes in Asia, which accounts for 60% of the world's sufferers. The firm has developed a device that monitors blood sugar levels and sends alerts to smartphone apps when it reaches dangerous levels. Health2Sync said within three months, high-risk users experienced a 22% drop in average blood glucose levels. The company, which recently closed a $6m series B round, aims to expand beyond its main market in Japan into southeast Asia.